Zeba Aziz

3.2k total citations
73 papers, 2.0k citations indexed

About

Zeba Aziz is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Zeba Aziz has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 15 papers in Hematology and 13 papers in Genetics. Recurrent topics in Zeba Aziz's work include Chronic Lymphocytic Leukemia Research (12 papers), Global Cancer Incidence and Screening (11 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Zeba Aziz is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Global Cancer Incidence and Screening (11 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Zeba Aziz collaborates with scholars based in Pakistan, United States and India. Zeba Aziz's co-authors include Imtiaz A. Malik, Wajahat Ali Khan, Henry Gómez, Michael Arbushites, Steven H. Stein, José Bines, Angelo Di Leo, Zanete Zvirbule, Judy Dering and María Koehler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Zeba Aziz

66 papers receiving 1.9k citations

Peers

Countries citing papers authored by Zeba Aziz

Since Specialization

Citations

This map shows the geographic impact of Zeba Aziz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeba Aziz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeba Aziz more than expected).

Fields of papers citing papers by Zeba Aziz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeba Aziz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeba Aziz. The network helps show where Zeba Aziz may publish in the future.

Co-authorship network of co-authors of Zeba Aziz

This figure shows the co-authorship network connecting the top 25 collaborators of Zeba Aziz. A scholar is included among the top collaborators of Zeba Aziz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeba Aziz. Zeba Aziz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive analysis of antibiotic resistance and gene expression patterns in Enterococcus spp. isolated from clinical samples in Al Muthanna, Iraq 2025 ·Gene Reports ·Zeba Aziz, (unknown)	0
2	Geriatric Assessment: ASCO Global Guideline 2025 ·JCO Global Oncology ·Cristiane Decat Bergerot, Sarah Temin, (unknown), Matti Aapro, Shabbir M.H. Alibhai, Zeba Aziz, (unknown), (unknown), Martine Extermann, Ravindran Kanesvaran, Bogda Koczwara, Kah Poh Loh, (unknown), (unknown), Vanita Noronha, Grant R. Williams, Enrique Soto‐Pérez‐de‐Celis	0
3	ASCO Global Guidelines: Methods and Opportunities 2024 ·JCO Global Oncology ·Zeba Aziz, Sarah Temin, (unknown), Gilberto Lopes, Temidayo Fadelu	0
4	Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline 2022 ·Obstetrical & Gynecological Survey ·Verna Vanderpuye, Jean R. Clemenceau, Sarah Temin, Zeba Aziz, William M. Burke, (unknown), Linus Chuang, Terence J. Colgan, Marcela G. del Carmen, Keiichi Fujiwara, Elise C. Kohn, (unknown), Thomas O. Konney, Asima Mukhopadhyay, Bishnu Dutta Paudel, (unknown), Sarikapan Wilailak, Rahel Ghebre	2
5	“Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan” 2022 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Raheel Iftikhar, (unknown), Zeba Aziz, (unknown), (unknown), (unknown), (unknown), (unknown)	4
6	Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline 2021 ·JCO Global Oncology ·Verna Vanderpuye, Jean R. Clemenceau, Sarah Temin, Zeba Aziz, William M. Burke, (unknown), Linus Chuang, Terence J. Colgan, Marcela G. del Carmen, Keiichi Fujiwara, Elise C. Kohn, (unknown), Thomas O. Konney, Asima Mukhopadhyay, Bishnu Dutta Paudel, (unknown), Sarikapan Wilailak, Rahel Ghebre	38
7	A Multicenter Study of Clinical Presentations and Outcomes of Multiple Myeloma in Pakistan: The Real-World Analysis in a Resource-Constrained Country 2021 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), (unknown), (unknown), (unknown), Neelam Siddiqui, Zeba Aziz, (unknown), (unknown), Imran Ahmad, (unknown)	1
8	Symposium: “Oncology Leadership in Asia” 2017 ·Cancer Research and Treatment ·Dong‐Young Noh, Jae Kyung Roh, Yeul Hong Kim, Kazuhiro Yoshida, Hideo Baba, (unknown), Sanjeev Misra, Zeba Aziz, Rainy Umbas, (unknown), Tony Mok, Han‐Kwang Yang, Hideyuki Akaza	3
9	Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer 2010 ·Current Medical Research and Opinion ·Beth Sherrill, Angelo Di Leo, Mayur M. Amonkar, Yun Wu, Zanete Zvirbule, Zeba Aziz, José Bines, Henry Gómez	12
10	Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial 2009 ·The Lancet Oncology ·Steven M. Grunberg, Janusz Rolski, (unknown), Zeba Aziz, Stephen Lane, Mark W. Russo, Paul Wissel, Mary Guckert, Oliver Wright, Jørn Herrstedt	47
11	Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer 2008 ·Journal of Clinical Oncology ·Angelo Di Leo, Henry Gómez, Zeba Aziz, Zanete Zvirbule, José Bines, Michael Arbushites, (unknown), María Koehler, Cristina Oliva, Steven H. Stein, Lisa S. Williams, Judy Dering, Richard S. Finn, Michael F. Press	345
12	Brief Continuing Medical Education (CME) Module Raises Knowledge of Developing Country Physicians. 2006 ·Amr S. Soliman, (unknown), Mousumi Banerjee, Robert M. Chamberlain, Zeba Aziz	13
13	Institution based tumor registry from Punjab: five year data based analysis. 2003 ·PubMed ·Zeba Aziz, (unknown), (unknown), Muhammad Tahir Akram	39
14	Prospective Evaluation of Efficacy and Toxicity of 5-FU and Folinic Acid (Mayo Clinic Regimen) in Patients With Advanced Cancer of the Gallbladder 2003 ·American Journal of Clinical Oncology ·Imtiaz A. Malik, Zeba Aziz	20
15	Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan 2002 ·The American Journal of Human Genetics ·Alexander Liede, Imtiaz A. Malik, Zeba Aziz, (unknown), Elaine Kwan, Steven A. Narod	122
16	A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia 1998 ·The American Journal of Medicine ·Imtiaz A. Malik, (unknown), Zeba Aziz, Shireen Khan, (unknown)	73
17	Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer 1998 ·Australian and New Zealand Journal of Medicine ·Zeba Aziz, Mohammad Faizan Zahid, (unknown), Tamoore Arshad	4
18	A multicenter study of recombinant human erythropoietin (epoetin α) in the management of anemia in cancer patients receiving chemotherapy 1997 ·Anti-Cancer Drugs ·Marek Pawlicki, Jacek Jassem, P Bõsze, (unknown), (unknown), Mohammed Siddiqui, P. Kosmidis, Gerasimos Rigatos, Emin Kansu, (unknown), Zeba Aziz, (unknown), Anton Roth, Gabriel Veniamin Cozma	14
19	Modified BFM protocol for childhood acute lymphoblastic leukemia: A retrospective analysis 1997 ·Medical and Pediatric Oncology ·Zeba Aziz, Maliha Zahid, Rashid Mahmood, (unknown)	9
20	Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in pakistan 1995 ·Medical and Pediatric Oncology ·Imtiaz A. Malik, (unknown), Azam Shafquat, Zeba Aziz, Hizbullah Shaikh, Wasim Jafri, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact